Power-dependent patients are spending anguishing hours in Ecuador, where a pattern of scheduled electricity outages is ...

13, 2024 — Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with ... technology to identify patterns of DNA fragments ...

Ibex Medical Analytics , the leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the publication of a clinical study evaluating Ibex Breast HER2 in ...

Stage IV cancers have spread (metastasized) beyond the breast and nearby lymph nodes to other parts of the body. When breast cancer spreads, it most commonly goes to the bones, liver, and lungs. It ...

Pfizer intends to achieve this goal through a combination of new drugs and additional indications for existing ones.

Sixteen doses of chemotherapy sent Breanne Hillen's breast cancer into remission ... up to seven hours." The cap's price, about $1,500, is also an obstacle for some patients.

This program marks the first application of DNAbilize technology to develop a non-cancer application ... relapsed acute myeloid leukemia (AML) patients, including venetoclax-resistant patients.

PanCAN Patient Services is the place to contact when facing pancreatic cancer. Our highly trained and compassionate Case Managers provide free, personal one-to-one support and information about the ...

The National University Health System and National University of Singapore CAR T team of Dr Esther Chan (left), Dr Bernice Oh (centre) and Professor Allen Yeoh at the National University Hospital ...

Ford Motor Co. has a solution for breast cancer patients who find driving difficult after a mastectomy because the seat belt is too painful. The automaker has contracted with Lear Corp.

KATHLEEN, Ga. — In the heart of Central Georgia, a haunted attraction is proving that sometimes the scariest things can lead to the most heartwarming outcomes. Lake Joy Trails of Terror, a ...

one patient died 95 days and another 211 days after the last dose of the study drug due to cancer relapse and pneumonia, respectively (not related to the study drug). Consistent with the findings ...